Report cover image

Global Type 2 Diabetes Mellitus Treatment Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 198 Pages
SKU # APRC20283068

Description

Summary

According to APO Research, The global Type 2 Diabetes Mellitus Treatment market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Type 2 Diabetes Mellitus Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Type 2 Diabetes Mellitus Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Type 2 Diabetes Mellitus Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Type 2 Diabetes Mellitus Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Type 2 Diabetes Mellitus Treatment include Takeda Pharmaceutical Co. Ltd, Sanofi SA, Novartis AG, Novo Nordisk AS, Merck & Co. Inc, Eli Lilly and Co., Daiichi Sankyo Co. Ltd, Boehringer Ingelheim International GmbH and AstraZeneca PLC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Type 2 Diabetes Mellitus Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Type 2 Diabetes Mellitus Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Type 2 Diabetes Mellitus Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Type 2 Diabetes Mellitus Treatment revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Type 2 Diabetes Mellitus Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Type 2 Diabetes Mellitus Treatment revenue, projected growth trends, production technology, application and end-user industry.

Type 2 Diabetes Mellitus Treatment Segment by Company

Takeda Pharmaceutical Co. Ltd
Sanofi SA
Novartis AG
Novo Nordisk AS
Merck & Co. Inc
Eli Lilly and Co.
Daiichi Sankyo Co. Ltd
Boehringer Ingelheim International GmbH
AstraZeneca PLC
Type 2 Diabetes Mellitus Treatment Segment by Type

Insulin
SGLT2 Inhibitors
GLP-1 Receptor Agonists
DPP-4 Inhibitors
Others
Type 2 Diabetes Mellitus Treatment Segment by Application

Hospitals
Clinics
Other
Type 2 Diabetes Mellitus Treatment Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 2 Diabetes Mellitus Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Type 2 Diabetes Mellitus Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 2 Diabetes Mellitus Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Type 2 Diabetes Mellitus Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Type 2 Diabetes Mellitus Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Type 2 Diabetes Mellitus Treatment revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Type 2 Diabetes Mellitus Treatment Market by Type
1.2.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Insulin
1.2.3 SGLT2 Inhibitors
1.2.4 GLP-1 Receptor Agonists
1.2.5 DPP-4 Inhibitors
1.2.6 Others
1.3 Type 2 Diabetes Mellitus Treatment Market by Application
1.3.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Type 2 Diabetes Mellitus Treatment Market Dynamics
2.1 Type 2 Diabetes Mellitus Treatment Industry Trends
2.2 Type 2 Diabetes Mellitus Treatment Industry Drivers
2.3 Type 2 Diabetes Mellitus Treatment Industry Opportunities and Challenges
2.4 Type 2 Diabetes Mellitus Treatment Industry Restraints
3 Global Growth Perspective
3.1 Global Type 2 Diabetes Mellitus Treatment Market Perspective (2020-2031)
3.2 Global Type 2 Diabetes Mellitus Treatment Growth Trends by Region
3.2.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2020-2025)
3.2.3 Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Type 2 Diabetes Mellitus Treatment Revenue by Players
4.1.1 Global Type 2 Diabetes Mellitus Treatment Revenue by Players (2020-2025)
4.1.2 Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Players (2020-2025)
4.1.3 Global Type 2 Diabetes Mellitus Treatment Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Type 2 Diabetes Mellitus Treatment Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Type 2 Diabetes Mellitus Treatment Key Players Headquarters & Area Served
4.4 Global Type 2 Diabetes Mellitus Treatment Players, Product Type & Application
4.5 Global Type 2 Diabetes Mellitus Treatment Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Type 2 Diabetes Mellitus Treatment Market CR5 and HHI
4.6.3 2024 Type 2 Diabetes Mellitus Treatment Tier 1, Tier 2, and Tier 3
5 Type 2 Diabetes Mellitus Treatment Market Size by Type
5.1 Global Type 2 Diabetes Mellitus Treatment Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Type 2 Diabetes Mellitus Treatment Revenue by Type (2020-2031)
5.3 Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Type (2020-2031)
6 Type 2 Diabetes Mellitus Treatment Market Size by Application
6.1 Global Type 2 Diabetes Mellitus Treatment Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Type 2 Diabetes Mellitus Treatment Revenue by Application (2020-2031)
6.3 Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Takeda Pharmaceutical Co. Ltd
7.1.1 Takeda Pharmaceutical Co. Ltd Comapny Information
7.1.2 Takeda Pharmaceutical Co. Ltd Business Overview
7.1.3 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2020-2025)
7.1.4 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
7.1.5 Takeda Pharmaceutical Co. Ltd Recent Developments
7.2 Sanofi SA
7.2.1 Sanofi SA Comapny Information
7.2.2 Sanofi SA Business Overview
7.2.3 Sanofi SA Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2020-2025)
7.2.4 Sanofi SA Type 2 Diabetes Mellitus Treatment Product Portfolio
7.2.5 Sanofi SA Recent Developments
7.3 Novartis AG
7.3.1 Novartis AG Comapny Information
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2020-2025)
7.3.4 Novartis AG Type 2 Diabetes Mellitus Treatment Product Portfolio
7.3.5 Novartis AG Recent Developments
7.4 Novo Nordisk AS
7.4.1 Novo Nordisk AS Comapny Information
7.4.2 Novo Nordisk AS Business Overview
7.4.3 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2020-2025)
7.4.4 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Product Portfolio
7.4.5 Novo Nordisk AS Recent Developments
7.5 Merck & Co. Inc
7.5.1 Merck & Co. Inc Comapny Information
7.5.2 Merck & Co. Inc Business Overview
7.5.3 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2020-2025)
7.5.4 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Product Portfolio
7.5.5 Merck & Co. Inc Recent Developments
7.6 Eli Lilly and Co.
7.6.1 Eli Lilly and Co. Comapny Information
7.6.2 Eli Lilly and Co. Business Overview
7.6.3 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2020-2025)
7.6.4 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Product Portfolio
7.6.5 Eli Lilly and Co. Recent Developments
7.7 Daiichi Sankyo Co. Ltd
7.7.1 Daiichi Sankyo Co. Ltd Comapny Information
7.7.2 Daiichi Sankyo Co. Ltd Business Overview
7.7.3 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2020-2025)
7.7.4 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
7.7.5 Daiichi Sankyo Co. Ltd Recent Developments
7.8 Boehringer Ingelheim International GmbH
7.8.1 Boehringer Ingelheim International GmbH Comapny Information
7.8.2 Boehringer Ingelheim International GmbH Business Overview
7.8.3 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2020-2025)
7.8.4 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Product Portfolio
7.8.5 Boehringer Ingelheim International GmbH Recent Developments
7.9 AstraZeneca PLC
7.9.1 AstraZeneca PLC Comapny Information
7.9.2 AstraZeneca PLC Business Overview
7.9.3 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2020-2025)
7.9.4 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Product Portfolio
7.9.5 AstraZeneca PLC Recent Developments
8 North America
8.1 North America Type 2 Diabetes Mellitus Treatment Revenue (2020-2031)
8.2 North America Type 2 Diabetes Mellitus Treatment Revenue by Type (2020-2031)
8.2.1 North America Type 2 Diabetes Mellitus Treatment Revenue by Type (2020-2025)
8.2.2 North America Type 2 Diabetes Mellitus Treatment Revenue by Type (2026-2031)
8.3 North America Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2020-2031)
8.4 North America Type 2 Diabetes Mellitus Treatment Revenue by Application (2020-2031)
8.4.1 North America Type 2 Diabetes Mellitus Treatment Revenue by Application (2020-2025)
8.4.2 North America Type 2 Diabetes Mellitus Treatment Revenue by Application (2026-2031)
8.5 North America Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2020-2031)
8.6 North America Type 2 Diabetes Mellitus Treatment Revenue by Country
8.6.1 North America Type 2 Diabetes Mellitus Treatment Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Type 2 Diabetes Mellitus Treatment Revenue by Country (2020-2025)
8.6.3 North America Type 2 Diabetes Mellitus Treatment Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Type 2 Diabetes Mellitus Treatment Revenue (2020-2031)
9.2 Europe Type 2 Diabetes Mellitus Treatment Revenue by Type (2020-2031)
9.2.1 Europe Type 2 Diabetes Mellitus Treatment Revenue by Type (2020-2025)
9.2.2 Europe Type 2 Diabetes Mellitus Treatment Revenue by Type (2026-2031)
9.3 Europe Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2020-2031)
9.4 Europe Type 2 Diabetes Mellitus Treatment Revenue by Application (2020-2031)
9.4.1 Europe Type 2 Diabetes Mellitus Treatment Revenue by Application (2020-2025)
9.4.2 Europe Type 2 Diabetes Mellitus Treatment Revenue by Application (2026-2031)
9.5 Europe Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2020-2031)
9.6 Europe Type 2 Diabetes Mellitus Treatment Revenue by Country
9.6.1 Europe Type 2 Diabetes Mellitus Treatment Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Type 2 Diabetes Mellitus Treatment Revenue by Country (2020-2025)
9.6.3 Europe Type 2 Diabetes Mellitus Treatment Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Type 2 Diabetes Mellitus Treatment Revenue (2020-2031)
10.2 China Type 2 Diabetes Mellitus Treatment Revenue by Type (2020-2031)
10.2.1 China Type 2 Diabetes Mellitus Treatment Revenue by Type (2020-2025)
10.2.2 China Type 2 Diabetes Mellitus Treatment Revenue by Type (2026-2031)
10.3 China Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2020-2031)
10.4 China Type 2 Diabetes Mellitus Treatment Revenue by Application (2020-2031)
10.4.1 China Type 2 Diabetes Mellitus Treatment Revenue by Application (2020-2025)
10.4.2 China Type 2 Diabetes Mellitus Treatment Revenue by Application (2026-2031)
10.5 China Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Type 2 Diabetes Mellitus Treatment Revenue (2020-2031)
11.2 Asia Type 2 Diabetes Mellitus Treatment Revenue by Type (2020-2031)
11.2.1 Asia Type 2 Diabetes Mellitus Treatment Revenue by Type (2020-2025)
11.2.2 Asia Type 2 Diabetes Mellitus Treatment Revenue by Type (2026-2031)
11.3 Asia Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2020-2031)
11.4 Asia Type 2 Diabetes Mellitus Treatment Revenue by Application (2020-2031)
11.4.1 Asia Type 2 Diabetes Mellitus Treatment Revenue by Application (2020-2025)
11.4.2 Asia Type 2 Diabetes Mellitus Treatment Revenue by Application (2026-2031)
11.5 Asia Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2020-2031)
11.6 Asia Type 2 Diabetes Mellitus Treatment Revenue by Country
11.6.1 Asia Type 2 Diabetes Mellitus Treatment Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Type 2 Diabetes Mellitus Treatment Revenue by Country (2020-2025)
11.6.3 Asia Type 2 Diabetes Mellitus Treatment Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Type 2 Diabetes Mellitus Treatment Revenue (2020-2031)
12.2 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Type (2020-2031)
12.2.1 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Type (2020-2025)
12.2.2 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Type (2026-2031)
12.3 SAMEA Type 2 Diabetes Mellitus Treatment Revenue Share by Type (2020-2031)
12.4 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Application (2020-2031)
12.4.1 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Application (2020-2025)
12.4.2 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Application (2026-2031)
12.5 SAMEA Type 2 Diabetes Mellitus Treatment Revenue Share by Application (2020-2031)
12.6 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Country
12.6.1 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Country (2020-2025)
12.6.3 SAMEA Type 2 Diabetes Mellitus Treatment Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.